ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PETROS AYELE MD INTERNAL MED.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,776Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 1171

$803K Total Retail Price of All Prescriptions

Rank: 71 out of 1171

473 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 436 379 1 1
LISINOPRIL 391 369 2 3
AMLODIPINE BESYLATE 375 319 3 2
LEVOTHYROXINE SODIUM 352 325 4 4
OMEPRAZOLE 350 334 5 5
WARFARIN SODIUM 294 236 6 12
FUROSEMIDE 279 266 7 6
MIRTAZAPINE 266 237 8 50
HYDROCODONE-ACETAMINOPHEN 244 231 S3 9 8
METFORMIN HCL 238 205 10 7
METOPROLOL TARTRATE 238 179 10 11
QUETIAPINE FUMARATE 199 171 12 54
CITALOPRAM HBR 181 153 13 22
NAMENDA 173 173 14 42
GABAPENTIN 166 122 15 16
CLOPIDOGREL 161 152 16 35
CARVEDILOL 157 148 17 20
DONEPEZIL HCL 148 142 18 24
SERTRALINE HCL 146 94 19 23
LANTUS 136 109 20 46
DIOVAN 132 125 21 32
PANTOPRAZOLE SODIUM 129 115 22 29
TRAMADOL HCL 127 106 23 18
OXYCODONE-ACETAMINOPHEN 124 111 S2 24 59
ATORVASTATIN CALCIUM 116 96 25 10
POLYETHYLENE GLYCOL 3350 115 84 26 72
PLAVIX 113 110 27 55
NOVOLIN R 113 89 27 155
FAMOTIDINE 110 88 29 75
RISPERIDONE 108 89 30 77
ESCITALOPRAM OXALATE 107 98 31 69
LOSARTAN POTASSIUM 99 90 32 14
CYMBALTA 99 87 32 64
TAMSULOSIN HCL 96 78 34 28
GLIPIZIDE 95 94 35 47
TRAZODONE HCL 93 72 36 37
KLOR-CON M20 92 85 37 41
CARBIDOPA-LEVODOPA 92 81 37 107
ATENOLOL 89 77 39 15
DIVALPROEX SODIUM 86 54 40 106
LEVOFLOXACIN 86 79 40 105
EXELON 83 71 42 164
METOPROLOL SUCCINATE 81 79 43 17
SEROQUEL 77 73 44 120
ZOLPIDEM TARTRATE 75 71 45 21
PRAVASTATIN SODIUM 74 48 46 13
GLIMEPIRIDE 74 72 46 34
ERYTHROMYCIN 71 57 48 401
ALENDRONATE SODIUM 70 52 49 33
MELOXICAM 70 70 49 56
LYRICA 70 54 49 127
NYSTATIN 68 57 52 128
ADVAIR DISKUS 67 66 53 51
HYDRALAZINE HCL 65 62 54 60
LEVETIRACETAM 65 62 54 84
LACTULOSE 64 57 56 108
POTASSIUM CHLORIDE 63 62 57 19
RANITIDINE HCL 63 50 57 38
CLONIDINE HCL 60 16 59 45
SPIRIVA 60 60 59 57
NITROFURANTOIN 59 58 61 287
ALBUTEROL SULFATE 59 56 61 102
BACLOFEN 54 17 63 110
OXYBUTYNIN CHLORIDE ER 53 39 64 135
SPIRONOLACTONE 52 45 65 53
SANTYL 52 41 65 173
HYDROCHLOROTHIAZIDE 52 51 65 9
ALLOPURINOL 52 52 65 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.